Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 241 | Novozymes A/S (NSIS B.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 405.00 | 115.51 | 28.52% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 242 | Oersted A/S (ORSTED.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 413.60 | 109.23 | 26.41% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 243 | Novozymes A/S (NZYM B.CO) | XCSE | DK | 2023-12-31 | 1 month ago | DKK | 416.80 | 115.51 | 27.71% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 244 | Gyldendal A/S (GYLD.B.CO) | 2019-12-31 | 3 years ago | DKK | 422.00 | 487.02 | 115.41% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 245 | Dantax A/S (DANT.CO) | XCSE | DK | 2023-06-30 | 1 day ago | DKK | 424.00 | 420.85 | 99.26% | 229.77 | 54.19% | NCAV (Net-Net) | 229.77 | 54.19% |
| 246 | Novo Nordisk A/S (NOVO.B.CO) | 2019-12-31 | 3 years ago | DKK | 431.95 | 94.09 | 21.78% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 247 | Djurslands Bank A/S (DJUR.CO) | XCSE | DK | 2022-12-31 | 1 day ago | DKK | 515.00 | 656.06 | 127.39% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 248 | Investeringsselskabet Luxor A/S (LUXOR B.CO) | XCSE | DK | 2023-09-30 | 1 day ago | DKK | 520.00 | 804.83 | 154.78% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 249 | Royal Unibrew A/S (RBREW.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 526.00 | 261.43 | 49.70% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 250 | Schouw & Co A/S (SCHO.CO) | XCSE | DK | 2023-12-31 | 1 day ago | DKK | 563.00 | 645.18 | 114.60% | 0.00 | 0.00% | Enterprising | 353.72 | 62.83% |